三重大学医学部病理 Deficiency of tenascin-C attenuates liver

Slides:



Advertisements
Similar presentations
Expression of Large Tenascin-C Splice Variants by Hepatic Stellate Cells in Chronic Hepatitis C Dr.Amro El-karef Assistant Professor of Pathology Department.
Advertisements

LIVER CIRRHOSIS. Liver cirrhosis  Define Cirrhosis.  Recognize the types of cirrhosis.  Recognize the major causes and the pathogenetic mechanisms.
Wound Healing Dr. Raid Jastania.
The role of microfibrillar-associated protein 4 (MFAP4) in asthma Bartosz Pilecki PhD student Institute of Molecular Medicine University of Southern Denmark,
Supplementary Figure 1. Generation of hepatocyte-specific A20 knockout mice. Targeting scheme. Diagram showing the LoxP-flanked (Floxed) and the deleted.
Molecular Therapy - Nucleic Acids
Depletion of Apoptosis Signal-Regulating Kinase 1 Prevents Bile Duct Ligation–Induced Necroinflammation and Subsequent Peribiliary Fibrosis  Hirotsugu.
Connections in Behavioral Biology
Volume 24, Issue 3, Pages (March 2006)
Volume 139, Issue 1, Pages e7 (July 2010)
Volume 140, Issue 5, Pages (May 2011)
Platelet TGF-β1 deficiency decreases liver fibrosis in a mouse model of liver injury by Shahrouz Ghafoory, Rohan Varshney, Tyler Robison, Karim Kouzbari,
The Tumor Necrosis Factor Superfamily Molecule LIGHT Promotes Keratinocyte Activity and Skin Fibrosis  Rana Herro, Ricardo Da S. Antunes, Amelia R. Aguilera,
Volume 139, Issue 4, Pages e4 (October 2010)
Volume 123, Issue 5, Pages (November 2002)
Volume 78, Issue 3, Pages (August 2010)
Volume 131, Issue 1, Pages (July 2006)
Volume 76, Issue 1, Pages (July 2009)
Restoration of Corneal Transparency by Mesenchymal Stem Cells
Volume 78, Issue 4, Pages (August 2010)
Volume 91, Issue 2, Pages (February 2017)
Nazanin Farhadi, MSc, Laura Lambert, BA, Chiara Triulzi, PhD, Peter J
Volume 139, Issue 4, Pages e4 (October 2010)
Volume 137, Issue 6, Pages e2 (December 2009)
Volume 125, Issue 6, Pages (December 2003)
Jack C. Reidling, Nils Lambrecht, Mohammad Kassir, Hamid M. Said 
Volume 133, Issue 6, Pages (December 2007)
Volume 123, Issue 4, Pages (October 2002)
Volume 82, Issue 8, Pages (October 2012)
Volume 137, Issue 4, Pages e5 (October 2009)
Volume 134, Issue 3, Pages e2 (March 2008)
Volume 131, Issue 1, Pages (July 2006)
Anti-fibrotic Effects of Synthetic Oligodeoxynucleotide for TGF-β1 and Smad in an Animal Model of Liver Cirrhosis  Jung-Yeon Kim, Hyun-Jin An, Woon-Hae.
Volume 129, Issue 5, Pages (November 2005)
Volume 129, Issue 2, Pages (August 2005)
Volume 140, Issue 5, Pages (May 2011)
Volume 42, Issue 4, Pages (April 2005)
Volume 80, Issue 9, Pages (November 2011)
Volume 126, Issue 7, Pages (June 2004)
Volume 143, Issue 3, Pages e3 (September 2012)
Exploring the “Hair Growth–Wound Healing Connection”: Anagen Phase Promotes Wound Re-Epithelialization  David M. Ansell, Jennifer E. Kloepper, Helen A.
Does hemophilia slow down the development of liver fibrosis?
Volume 69, Issue 2, Pages (August 2018)
Approaches for treatment of liver fibrosis in chronic hepatitis C
Obesity, Inflammation, and Insulin Resistance
Volume 135, Issue 2, Pages (August 2008)
Fig. 6 pDCs infiltrate the skin of BLM-treated mice, and their depletion attenuates skin fibrosis. pDCs infiltrate the skin of BLM-treated mice, and their.
TWEAK/Fn14 Signals Mediate Burn Wound Repair
Hepatocyte growth factor suppresses interstitial fibrosis in a mouse model of obstructive nephropathy  Shinya Mizuno, Kunio Matsumoto, Toshikazu Nakamura 
Volume 39, Issue 5, Pages (November 2003)
IL-22 Promotes Fibroblast-Mediated Wound Repair in the Skin
Volume 16, Issue 1, Pages (July 2012)
Heat Shock Transcription Factor 1 Is a Key Determinant of HCC Development by Regulating Hepatic Steatosis and Metabolic Syndrome  Xiongjie Jin, Demetrius.
Volume 131, Issue 6, Pages (December 2006)
Volume 127, Issue 3, Pages (September 2004)
Increased Severity of Bleomycin-Induced Skin Fibrosis in Mice with Leukocyte-Specific Protein 1 Deficiency  JianFei Wang, Haiyan Jiao, Tara L. Stewart,
A Role for Estrogen Receptor-α and Estrogen Receptor-β in Collagen Biosynthesis in Mouse Skin  Margaret Markiewicz, Sergey Znoyko, Lukasz Stawski, Angela.
Robert L. Chevalier, Michael S. Forbes, Barbara A. Thornhill 
Osteopontin in Systemic Sclerosis and Its Role in Dermal Fibrosis
Syed M. Meeran, Thejass Punathil, Santosh K. Katiyar 
Macrophage heterogeneity in liver injury and fibrosis
CD4+ T cells: a potential player in renal fibrosis
Silvia Affò, Ramón Bataller  Journal of Hepatology 
Volume 132, Issue 5, Pages (May 2007)
Molecular Therapy - Nucleic Acids
miR-29 Inhibits Bleomycin-induced Pulmonary Fibrosis in Mice
MicroRNA-125b Promotes Hepatic Stellate Cell Activation and Liver Fibrosis by Activating RhoA Signaling  Kai You, Song-Yang Li, Jiao Gong, Jian-Hong Fang,
Liver fibrosis after CCl4 injury in 5αR1-KO and WT mice.
Volume 21, Issue 2, Pages (February 2013)
Volume 137, Issue 6, Pages e2 (December 2009)
Presentation transcript:

三重大学医学部病理 Deficiency of tenascin-C attenuates liver fibrosis in immune-mediated chronic hepatitis in mice 三重大学医学部病理 El-Karef Amro 303D006

Progression from Hepatitis to Fibrosis Chronic liver diseases Viral Hepatitis, Autoimmune Hepatitis etc Inflammatory Response Hepatocyte Injury T Lymphocytes Kupffer Cells Activation and Recruitment of HSCs (Hepatic Stellate Cells) & MFBs (Portal Myofibroblasts) Collagen Synthesis Liver Fibrosis (Cirrhosis)

Tenascin-C (TN-C) in Chronic Liver Diseases highly expressed in chronic viral hepatitis, autoimmune hepatitis and bile obstruction highly deposited in interfaces of fibrotic areas and in peri-sinusoidal spaces synthesized by HSCs Possible involvement in liver fibrosis

Molecular model of the subunit Tenascin-C (TNC) is an ECM glycoprotein upregulated in remodeling tissues Hexameric Structure FNIII Repeat TA EGFL Repeats Alternatively spliced region FG 1 2 3 4 5 A1 A2 A3 A4 B AD2 AD1 C D 6 7 8 Molecular model of the subunit

Mice develop normally without Tenascin-C (Saga Y et al. Gene Dev 1992) Tenascin-C Knockout (TNKO) Mice Mice develop normally without Tenascin-C (Saga Y et al. Gene Dev 1992) Abnormal repair in diseased tissues of adult mice Neuromuscular junction Venom-induced glomerulonephritis Chemically induced dermatitis Corneal injury Granulation tissue after cardiac injury

Aim of Study Immune-mediated chronic hepatitis model [ Concanavalin A (ConA)-induced ] × WT mice and TNKO mice To obtain direct evidence for promotive roles of TNC in live fibrosis

Experimental Protocol of ConA Challenge 8-week-old female BALB/c mice Experimental Groups ConA challenges (20 mg/Kg/ week, i.v.) 12w 0w 13w x 9w sacrifice x 6w x 3w x Saline alone Controls CTL2 x CTL1 x

Histological and Biochemical Analyses Histological & immunohitochemical staining: - H&E: Histological analyses for necrosis and inflammation. - Picrosirus red: Deposited collagen fibrils - TNC: TNC protein - a smooth muscle actin (α-SMA ): Activated HSCs/MFBs Liver RNA extraction & RT-PCR: - Quantitative real-time PCR (qPCR) ECM proteins: TNC – Collagen I & III Inflammatory cytokines: INF-γ, IL-4 & TNF-α Fibrogenic cytokine: TGF-β

Immunohistochemical staining of TNC Liver tissues of WT mice CTL1 3w 6w 9w TNC deposition is gradually increased after ConA administration. 12w CTL2

RT- PCR and qPCR for TNC mRNA 6 p<0.01 p<0.001 5 b-actin TNC - 540 - 344 4 p<0.01 p<0.05 TNC mRNA (folds) 3 2 CTL1 3w 6w 9w 12w CTL2 1 Conventional PCR CTL1 3w 6w 9w 12w CTL2 Quantitative real time PCR TNC mRNA levels sequentially increase in WT livers.

Collagen deposition of WT & TNKO mice livers CTL2 12w Picrosirius red staining Collagen deposition was less intense in TNKO mice after 12th ConA injection (12w) than WT mice.

Image analysis of fibrosis WT TNKO Total liver fibrosis Parenchymal fibrosis 25 7 p<0.001 p<0.001 p<0.05 p<0.001 p<0.05 ns p<0.05 p<0.01 20 6 5 15 Fibrotic area (%) 4 Fibrotic area (%) 10 3 2 5 1 CTL1 3w 6w 9w 12w CTL2 CTL1 3w 6w 9w 12w CTL2 Quantification was performed by NIH image using picrosirius red-stained sections Fibrosis areas in WT liver were more than in TNKO.

qPCR for procollagen I & III mRNA WT TNKO Procollagen I Procollagen III 6 4 p<0.05 p<0.05 p<0.01 p<0.001 p<0.01 p<0.05 p<0.001 p<0.05 5 Wild 3 KO Wild 4 KO COL1A2 mRNA (folds) COL3A1 mRNA (folds) 3 2 2 1 1 CTL1 3w 6w 9w 12w CTL2 CTL1 3w 6w 9w 12w CTL2 Procollagen I & III expression was upregulated in WT mice livers than in TNKO.

How could TNC promote liver fibrosis? TNC expressed in WT mice can contribute to liver fibrosis. How could TNC promote liver fibrosis?

Inflammatory cell infiltrate in WT & TNKO mice CV PT PT: portal tract CV: central vein TNKO PT CV Inflammatory infiltrate was more severe in WT mice livers than in TNKO.

Semi-quantification of the inflammatory infiltrate WT TNKO * ns ns * * p<0.05 3 3 2 2 2 4 2 Lymphocytic Infiltration 1 3 1 4 3 3 4 2 3 1 2 1 3w 6w 9w 12w modified Knodell’s HAI scoring system Lymphocytic infiltrate scores were significantly higher in WT than in TNKO after Con A administration

qPCR of inflammatory cytokines mRNA 2 4 6 8 10 12 CTL1 3w 6w 9w 12w CTL2 INF - γ mRNA (fold value) ** * *** IL 4 mRNA TNF a WT TNKO * p<0.05 ** p<0.01 *** p<0.001 Cytokines were significantly upregulated in WT than in TNKO.

α-SMA immunostaining of WT & TNKO liver PT: portal tract CV: central vein Arrows: Positive cells (Activated HSCs/MFBs) α-SMA positive cells were more common in WT than in TNKO.

a-SMA-positive cells ( /mm2 ) α-SMA positive cell counts WT TNKO p<0.001 p<0.05 p<0.01 300 200 a-SMA-positive cells ( /mm2 ) 100 CTL1 3w 6w 9w 12w CTL2 α-SMA positive cells significantly increased to a greater extent in WT than in TNKO.

qPCR for TGF-β mRNA WT TNKO 5 p<0.01 p<0.001 p<0.001 4 3 TGF-β1 mRNA (folds) 2 1 CTL1 3w 6w 9w 12w CTL2 TGF-β1 mRNA was significantly increased in WT than in TNKO.

TNC TNC promotes inflammatory response & cytokine upregulation Con A Rolling ↑ Migration ↑ TNC Liver Activated T lymphocyte Cytokines ↑ INF-γ INF-γ IL- 4 Kupffer cell Liver cell injury TNF-α (IL-1)

TNC TNC promotes activation of HSC Liver cell injury Liver Inflammatory Response ↑ Liver cell injury TNF-α Kupffer cell TNF-α (Lipid metabolites) Phenotypic change ↑ (IL-1, NO, O*) Quiescent HSC Activated HSC (a-SMA +)

TNC TNC promotes recruitment of HSCs/MFBs & TGF-b upregulation Liver Activated HSC (a-SMA +) Quiescent HSC TGF-b Expression/ Signaling ↑ TNC HSC proliferation TGF-b Activation & Migration ↑ Activated MFBs (a-SMA +) Portal MFBs

TNC-rich Matrix TNC HSCs/MFBs provides TNC-rich matrix Liver TGF-b Activated HSC (a-SMA +) Quiescent HSC TGF-b Expression/ Signaling ↑ TNC-rich Matrix TNC HSC proliferation TGF-b Activation & Migration ↑ Activated MFBs (a-SMA +) Portal MFBs

Procollagen ↑ Fibrosis TNC TNC promotes liver fibrosis Liver TGF-b Activated HSC (a-SMA +) Quiescent HSC TGF-b Expression/ Signaling ↑ Procollagen ↑ Fibrosis TNC HSC proliferation TGF-b Activation & Migration ↑ Activated MFBs (a-SMA +) Portal MFBs

Conclusion Tenascin-C actively contributes to hepatic fibrosis through possible mechanisms as follows: Augments the inflammatory response & upregulates inflammatory cytokines as INF-γ, IL-4 & TNF-α. Recruits & activates HSCs & MFBs. Up-regulates TGF-β.